The US Cyber Trust Mark and Its Implications for IoMT Security in Healthcare 

The US Cyber Trust Mark and Its Implications for IoMT Security in Healthcare Avakash Dekavadiya The evolution of IoMT and Connected Medical Devices: A little background before we move towards what if means for the IoMT and Medical Device Companies: In recent years, the healthcare industry has witnessed a significant shift towards interconnected medical devices, driven by the Internet of Medical Things (IoMT). As the use of these devices becomes more prevalent, the need for robust cybersecurity measures to protect patient data and ensure patient safety has never been more critical.   In this third installment of our series on FDA cybersecurity updates, we explore the US Cyber Trust Mark and its potential implications for the security of IoMT devices in healthcare. In this series, we have tried to cover the entire roadmap of a medical device right from FDA cybersecurity requirements during PMA or 510(k) submissions, cybersecurity recommendations by FDA post-market and now this, the potential of Cyber Trust Mark- another initiative under Omnibus.  The Birth of the US Cyber Trust Mark: In July 2023, the Biden-Harris Administration introduced the US Cyber Trust Mark, a cybersecurity labeling program designed for Internet of Things (IoT) devices. The primary goal of this initiative, proposed by Federal Communications Commission (FCC) Chairwoman Jessica Rosenworcel, is to empower consumers with cybersecurity assurances when purchasing smart devices for their homes. This labeling program, similar to the well-known Energy Star program for energy-efficient appliances, is set to feature on devices that meet strict cybersecurity standards established by the National Institute of Standards and Technology (NIST). It will provide consumers with the confidence that the devices they choose adhere to cybersecurity criteria such as strong default passwords, regular software updates, and incident detection capabilities. Implications of Cyber Security mark on Healthcare: While the US Cyber Trust Mark program initially targets consumer IoT devices, it has the potential to extend its influence to the realm of healthcare, particularly the Internet of Medical Things (IoMT). This development aligns with the growing need for enhanced security in healthcare, given the increasing use of IoMT devices and telehealth solutions. IoMT devices, just like consumer IoT devices, collect sensitive patient data and are prone to cyberattacks. The consequences of a breach in the healthcare sector can range from minor inconveniences to critical patient harm, including life-threatening injuries and even patient deaths. Therefore, establishing a trust mark for IoMT devices becomes a crucial step in ensuring patient safety. Streamlining Security Assurance Processes: The introduction of the US Cyber Trust Mark marks a shift towards a more active government role in enforcing cybersecurity standards. It signifies the government’s commitment to providing consumers with a reliable indicator of device security, which is a positive development for both consumers and the industry. While the initial focus is on consumer devices, there’s a growing expectation that IoMT devices will also benefit from this program. As the government refines the program and expands its scope, IoMT devices could see some form of certification as well. A Complex Landscape that will require industry and technical expertise: It’s important to note that managing the cybersecurity of IoMT devices is more complex than consumer IoT devices. The lifespan of healthcare devices, such as MRI machines, can span decades, whereas consumer devices like fitness trackers have a shorter lifespan. Additionally, the healthcare industry must adhere to stringent compliance requirements and validation controls. Thus, while the government prepares for the launch of Cyber Trust market and its certifications, medical device companies must also gear up their Cybersecurity readiness as well as cybersecurity and interoperability testing along with design and security V&V services. Once these protocols and changes are established, the US Cyber Trust Mark can streamline processes and serve as an additional tool for healthcare delivery organizations (HDOs) to confidently select secure IoMT devices like yours. The certification could help HDOs identify and procure devices with stronger security, ultimately expanding their fleets with greater speed and confidence with your devices. The way forward: The future of IoMT security is taking shape with the introduction of the US Cyber Trust Mark. While the government plays a role in setting standards and providing certifications, organizations must continue to take charge of device management and establish internal processes to address security vulnerabilities effectively. As the program develops and its influence expands, medical device manufacturers and healthcare organizations should closely monitor government certification requirements. By doing so, they can ensure that more secure consumer and hospital-grade devices reach the market quickly. The US Cyber Trust Mark is a positive development for IoMT security, offering consumers a reliable indicator of device security and potentially transforming the healthcare industry’s approach to cybersecurity. Irrespective whether you are a start-up looking for FDA approval or an established medical device company trying to establish trust, we at AIMDek can help with your regulatory documentation, V&V Testing as well as Cybersecurity readiness! To understand how we can custom tailor our MedTech service for your organization; connect with our MedTech experts today. Also, don’t forget to inquire about our no-obligation architecture review when you schedule the call! skip render: ucaddon_next_prev_post

Revamped FDA Medical Device Security Requirements- Post Market Cybersecurity Management!

Revamped FDA Medical Device Security Requirements- Post Market Cybersecurity Management! Avakash Dekavadiya Avakash Dekavadiya Cyberattacks are becoming more sophisticated and healthcare has been a primary target due to the integral patient information. Especially in healthcare, attackers have been finding vulnerabilities and ways to get access to information generated by medical devices. With their abilities of remote and continuous monitoring, the use of medical devices has increased exponentially and so have the cyberattacks on IoMT and Medical Devices due to the valuable medical information they collect 24*7. But, the harm of getting access to Class 2 and Class 3 medical devices is not just limited to the leak of information. By gaining access to medical devices, attackers can control the devices and when exposed to vulnerability can result in minor to catastrophic consequences of patient harm. Due to such implications, the FDA has asked Medical Device companies to not only consider Cybersecurity in pre-market submissions but also roll out post-market recommendations. Thus, medical device companies who wish to market their products in the United States must adhere not only to cybersecurity requirements during the PMA submissions, but also to post-market recommendations and create a secure cybersecurity approach that can help them identify, protect, detect, assess, and respond to cybersecurity vulnerabilities and attacks. While non-adherence to Cybersecurity requirements in PMA can lead to a Refuse to Accept letter from the FDA which then denies the product to be sold and marketed in the US market, post-market recommendations are essential as the FDA has introduced periodic annual cybersecurity reviews where medical device companies must submit Cybersecurity vulnerabilities and failure to address vulnerabilities can lead to product recall or ban of use! In this 3-blog series, the first blog talks explicitly about pre-market cybersecurity requirements from the FDA and in this, we talk about post-market recommendations from the FDA along with ideal ways to manage Cyberattacks! Thus, below are the FDA’s post-market Cybersecurity recommendations that would help in periodic annual reviews and in establishing effective cybersecurity approaches that can help medical device companies manage vulnerabilities and avoid patient harm from cyberattacks. FDA’s post-market Cybersecurity recommendations: Before we move to the recommendations, let’s first understand why the FDA emphasizes on Cybersecurity; what kind of patient harm can cyber attacks cause and how does FDA recognizes patient harm. According to the FDA, “Patient harm is defined as physical injury or damage to the health of patients, including death. Health risks posed by the device may result in patient harm.” Types of Patient harm and their effect defined by FDA: Negligible: Inconvenience or temporary discomfort Minor: Results in temporary injury or impairment not requiring professional medical intervention Serious: Results in injury or impairment requiring professional medical intervention Critical: Results in permanent impairment or life-threatening injury Catastrophic: Results in patient death Thus, to protect patients from this harm and to protect their integral medical information from getting into unauthorized hands, Cybersecurity risk management programs from the FDA emphasize addressing vulnerabilities that may permit unauthorized users to access, modification, misuse, or denial of use of a medical devices information which may result in patient harm. These programs span out the below-mentioned areas, and the FDA has the following recommendations for medical device companies: Response to identified and reported vulnerabilities: FDA recommends that Manufacturers must report and act on identified vulnerabilities by reporting them on time. To identify such vulnerabilities, the FDA suggests that Medical Device companies monitor the official sources where cybersecurity information is updated and consider all the suggested risks. Monitoring your device and associated off-the-shelf software: FDA recommends that medical device companies set up Cybersecurity protocols and processes across the software lifecycle. Along with the product and its software components, medical device companies must also monitor third-party software components for new vulnerabilities throughout the device’s total product lifecycle. Periodic Verification and Validation: From design verification and validation for software updates to software V&V, the FDA suggests medical device companies validate all their releases and deploy patches that are used to remediate vulnerabilities, including those related to Off-the-shelf software. Ways of identifying vulnerabilities in the system: To ensure that Medical Device companies can identify vulnerabilities in their system, they have to create procedures and periodic cybersecurity assessments to understand, assess and detect the presence and impact of a vulnerability. Establish processes for vulnerability intake and handling: Cybersecurity information about your Medical Device can originate from an array of sources such as independent security researchers, in-house testing, suppliers of software or hardware technology, healthcare facilities, and information sharing and analysis organizations. Medical Device companies must establish communication processes for vulnerability intake and handling. For vulnerability handling processes and security technology; the FDA has recognized ISO/IEC 30111:2013 act and its processes. Developing mitigations to protect, respond, and recover from the cybersecurity risk: With periodic device and system testing and using threat modeling with clearly defined protocols of optimum device safety and essential performance; medical device companies must create risk mitigation protocols that can minimize cyber threats and result in no patient harm with effective risk recovery. Periodic patch release and effective quality management systems: Lastly, medical device companies can’t divert and restrict all such cyber threats. Thus, it is essential that instead of planning to create an impenetrable system, medical device companies instead create a structured and systematic approach to risk management that complies with 21 CFR part 820. Also, organizations must make periodic patch releases and establish effective quality management systems. A steady walk towards a cyber-secure healthcare ecosystem: Along with submissions and post-approval processes, Medical Device Companies will have to consider functional changes in their SDLC that are suggested by the FDA, and down the line, the Healthcare Industry and MedTech industry must also prepare for the Cyber Security mark that might get issued by FDA to medical devices. In this 3-blog series that we have started at AIMDek, the first blog was about Pre-market application submissions while this covered post-market cybersecurity recommendations. The third blog will cover information about how Cybersecurity will impact medical devices and what to look for

FDA’s Revamped Medical Device Security Requirements- Gatekeeper that can Hold Medical Device’s Approval! 

FDA’s Revamped Medical Device Security Requirements- Gatekeeper that can Hold Medical Device’s Approval! Avakash Dekavadiya Cybersecurity takes Centre stage in the US market: After Data Interoperability, another aspect that the US government is focusing on in alignment with HHS and FDA is the cybersecurity of Medical Devices. With the increasing market of IoMT devices and increasing use of integrated healthcare systems that are connected to the internet, there will be a rise in the cyber devices and thus, the need for cybersecurity in medical/cyber devices becomes essential for optimum patient safety.  The timeline of occurrences that put Cybersecurity as a priority for Medical Devices Companies: The Consolidated Appropriations Act, of 2023 (“Omnibus”) was proposed by the US government and an integral part of the 4000+ page proposal was Medical Device’s cybersecurity. On December 29, 2022, the Consolidated Appropriations Act, 2023 (“Omnibus”) was signed into law. The law came into effect on March 29, 2023. An entire new section 3305 of the Omnibus is dedicated to ensuring the Cybersecurity of Medical Devices and based on the revamped requirements, the law provides FDA with the authority to scrutinize Medical Device applications from the Cybersecurity perspective.  One of the biggest changes that would impact the Medical Device Companies post these revamped security requirements is that from October 1, 2023, the FDA will have the authority to “Refuse To Accept” (RTA) Medical Device applications made under 510(k), premarket approval application (PMA), Product Development Protocol (PDP), De Novo, or Humanitarian Device Exemption (HDE) (while Cybersecurity was a requirement previously, FDA couldn’t reject applications based on Cybersecurity issues before).  To understand which medical devices are under scrutiny, you first must understand how the FDA defines a Cyber Device. What is a Cyber Device according to the FDA? Section 524B(c) of the FD&C Act defines “cyber device” as: “A device that includes software validated, installed, or authorized by the sponsor as a device that can connect to the internet, and contains any such technological characteristics validated, installed, or authorized by the sponsor that could be vulnerable to the cybersecurity threats.” This means any device that is vulnerable to cyber threats due to internet connectivity or uses any kind of integration that can provide unauthorized access to the device to cyber attackers is to be considered. Now that we know which devices are affected by these changes, let’s understand the overview of what the FDA expects Medical Device Companies to ensure when they talk about Cybersecurity. What are Medical Device Companies supposed to include in Cybersecurity documents that the FDA has revamped and requested? In the revamped security requirements, an FDA spokesperson stated that Medical Devices Companies must submit documents that provide a detailed “plan to monitor, identify, and address, as appropriate, in a reasonable time, post-market cybersecurity vulnerabilities and exploits, including coordinated vulnerability disclosure and related procedures”. Apart from that, manufacturers are also supposed to submit detailed plans in their Cyber Security documents the procedures that provide a reasonable assurance that the device and systems are cybersecure and incorporate plans to patch and update the device and related systems at the post-market stage. Apart from the device, its firmware, and software components, Medical Devices sometimes also have 3rd Party Integrations and for that, the manufacturers are also required to provide a software bill of materials (SBOM) for their devices, including commercial, open-source, and off-the-shelf software components to the FDA. What are the precautions or the steps that Medical Device Manufacturers can now take to include Cybersecurity in their Medical Device development stage and how can they align their product with FDA revamped requirements to avoid RTA? Below are some points to take into consideration: After all these updates, it is evident that FDA has put security as a priority for Medical Device Companies especially those IoMT and connected devices that are connected to the internet. For all those medical device companies, the right to incorporate is to include security as an aspect right from the start. Consider security aspects at all levels of Hardware Engineering and SDLC: Right from designing and developing the medical device, manufacturers will have to factor security into the blueprint of the product. (The FDA even suggests creating a security switch or button that can stop devices from being breached!) Along with that, security measures and precautions must also be considered during the Software Development Lifecycle. Ensure comprehensive security in the entire digital ecosystem of your device: To ensure that your device remains cyber secure, medical device companies must consider security in architecture design, while performing threat modeling, during risk analysis as well as during product and software testing! Thus, when you are testing your product and submitting it to the FDA for approval, be ready to demonstrate that your product is not only functionally, mechanically, electrically, and chemically safe, but also ensure that it is cyber safe. Think about the present as well as the future: FDA will ask for annual reports from Medical Device manufacturers regarding their cybersecurity measures. This annual report will incorporate: Vulnerabilities faced in the past year Steps taken to identify, report, and revert the damage of the vulnerability The rationale for choosing the approach to respond to the vulnerability References from another device that faced similar challenges (if any), their approach, and their response. Thus, based on these changes, manufacturers will not only have to ensure Cybersecurity during FDA approval submissions but also post-approval. Also, there are new regulations and changes expected from the FDA in the future, and thus, Medical Device Companies must incorporate processes and procedures to tackle Cybersecurity along with testing frameworks and QA automation processes in place to ensure continuous cybersecurity monitoring. A steady walk towards a cyber-secure healthcare ecosystem: Along with submissions and post-approval processes, Medical Device Companies will have to consider functional changes in their SDLC that are suggested by the FDA, and down the line, the Healthcare Industry and MedTech industry must also prepare for the Cyber Security mark that might get issued by FDA to medical devices.   In this 3 blog series

Comparing Liferay DXP and HCL DX: User Feedback Highlights 

Comparing Liferay DXP and HCL DX: User Feedback Highlights Avakash Dekavadiya The DXP market and its giants: When it comes to choosing a digital experience platform (DXP) for your organization, it’s essential to make an informed decision as it is directly co-related to your audience as well as stakeholders and it is also an investment that helps you gain a competitive edge in the market.   Talking about Enterprise DXP platforms, two leading options in the market are Liferay DXP and HCL Digital Experience (DX). HCL DX or WebSphere Portal is a renowned name in the market with technology giants like IBM and HCL (WebSphere was introduced by IBM in 2001 and later acquired by HCL). On the other end, Liferay has been recognized as the market leader in Gartner’s magic quadrant and they have won this title many times over the years. (Source). The power of Word Of Mouth: When it comes to making a decision, we humans trust our peers, experts, and first-hand users above any platform, AI, or other such tools. For instance, some statistics suggest that 90% of people trust a brand that is recommended by users (even by strangers). 88% of customers become loyal to a brand and show their trust when a friend or family member has recommended it. Lastly, when we talk about popular ways to recommend a business, word-of-mouth comes first, followed by Facebook, Google, and Twitter. (Source) Thus, to help you decide which one suits your needs, we’ll delve into the key factors that enterprises consider while selecting a DXP platform and point out the differences between these two platforms, with a particular focus on user feedback. Ease of Use Liferay DXP: Liferay DXP is often praised for its user-friendly interface, making it accessible for non-technical users. Users appreciate the drag-and-drop functionality, which simplifies content management and customization. The platform’s intuitive dashboard receives positive feedback for its ease of navigation. HCL Digital Experience: Some users find HCL DX to have a steeper learning curve, especially for those without prior experience in similar platforms. While powerful, HCL DX may require more technical expertise to fully harness its capabilities. The interface has received mixed reviews, with some users suggesting it could be more intuitive. User Feedback: Liferay is a solid portal, implemented in Java. The source is right there, so I can figure out how things work when I need to develop my own contributions. Michael B.Verified User in Information Technology and Services Features and Flexibility Liferay DXP: Liferay DXP offers a wide range of out-of-the-box features, including robust content management, social collaboration, and personalization tools. Users appreciate the flexibility of Liferay’s modular architecture, allowing for custom development and integration with other systems. The platform’s open-source nature encourages a thriving community of developers and readily available plugins. HCL Digital Experience: HCL DX is recognized for its enterprise-grade capabilities, making it suitable for large organizations with complex requirements. Users praise its extensive set of tools for creating personalized, data-driven experiences. Some find that the platform’s comprehensive feature set can be overwhelming for smaller businesses or projects with more straightforward needs. Negative: Very complex architecture for on-premise deployments (too many servers to installed) Positive: Easy customization Negative: Architecture limited to cloud solutions WCM is an old product and needs an update Blog, and community are not integrated in Digital Manager for discussion Templates are not available to integrate basic services (FileNet, more complex BPM , e-commerce) Jean-Luc TaillandierResponsable Technique IT Scalability and Performance Liferay DXP: Users report that Liferay DXP performs well in smaller to mid-sized implementations. The platform is seen as highly scalable, with many organizations successfully using it for larger projects. Performance and speed are generally considered satisfactory, but it may require optimization for extremely high traffic websites. HCL Digital Experience: HCL DX is designed with scalability in mind and is well-suited for large, high-traffic websites. Some users mention that HCL DX’s performance can be outstanding when properly configured and optimized However, there are reports of occasional performance challenges that may require expert tuning. IBM products always moves forward to adapt to new requirements and technologies. I have used versions 6, 6.1, 7 and 8 of IBM WCM, and I know IBM is ready to revamp the tool based on emerging needs, and still provide the capabilities to migrate your old system to the newer versions. Arwa Nababteh IBM WCM Developer/ team Leader Support and Community Liferay DXP: Liferay’s community and support are often commended for their responsiveness and helpfulness. Users appreciate the wealth of documentation and online resources available for problem-solving. Commercial support options are available for those who require additional assistance. HCL Digital Experience: HCL DX also offers robust support options, including 24/7 customer support for critical issues. Some users have noted positive experiences with HCL’s professional services, especially for complex deployments. But, it has also been observed and shared by users that finding skilled resources can be challenging for HCL. The platform has an active user community, but it may not be as extensive as Liferay’s. HCL DX does really well at managing and maintaining the site. It allows the business to basically maintain the site while IT spent time developing new and enhanced functions. The main issue I currently have with HCL DX is not directly with the product but it does play a role. It is difficult finding skilled resources to support HCL DX in my experience. Verified UserAnonymous It depends on your Business, Budget and Requirements: Both Liferay DXP and HCL Digital Experience have their strengths and weaknesses, and the choice between them should depend on your organization’s specific needs and resources. Liferay DXP is often favored for its user-friendliness and strong community, making it an excellent choice for smaller to mid-sized projects.   On the other hand, HCL DX is a robust solution suitable for large enterprises with complex requirements. User feedback highlights these distinctions and can help you make an informed decision based on your unique circumstances.  Looking for effective Liferay consulting? AIMDek is a Silver Liferay partner and can

Liferay Insurance Portals – Designed for Ecosystems and Tailored for Individuals 

Liferay Insurance Portals – Designed for Ecosystems and Tailored for Individuals Avakash Dekavadiya Insurance and its challenges in the ever-evolving Technology Landscape: Insurance is one such industry where players must be innovative not only with their products but with their approach, services, and customer user experiences as well. In the fast-paced and ever-evolving insurance industry, creating a seamless and personalized experience for both customers and employees is crucial for success.   Liferay, which has been recognized as the leading enterprise DXP solution for the insurance industry because of its OOTB functions and personalization capabilities, Liferay because of its significant investment in DXP solutions has become a valuable tool for insurance companies.   With Liferay insurance companies can not only enhance their digital presence, but also create a seamless digital transformation journey and employ a solution that rather than replacing their culture, workflows, and systems creates a bridge that fits effectively within the existing ecosystem.  Liferay’s Capabilities in the Insurance Industry: Ecosystem Integration: Liferay is built to connect and integrate various systems and data sources within the insurance ecosystem. It allows insurers to streamline processes by connecting back-end systems such as policy management, claims processing, and underwriting with front-end portals and customer touchpoints. Through APIs and microservices, Liferay enables insurers to create a unified ecosystem where customers, agents, brokers, and employees can access and share information seamlessly. Personalization and User Segmentation: Personalization is at the heart of Liferay’s capabilities. In the insurance industry, where customer preferences and needs can vary widely, personalizing the user experience is essential as well as complex. While each organization has its own unique approaches and user experience journeys, Liferay DXP with its flexible DXP core allows insurers to create individualized customer journeys. Along with flexibility and the ability for customization, Liferay DXP also comes with automation capabilities that can help create unique and personalized customer experiences at scale. For instance, using Liferay DXP core and its backend, enterprises can use customer data to segment users and provide tailored content, policy recommendations, and communication channels. Along with that, you can also leverage its analytics capabilities to gain insights regarding each customer and ensure that your agents, Customer Executives and Underwriters can cater to each customer’s unique needs.  Multi-Channel Engagement: In the era of omnichannel marketing, Insurance companies need to engage with customers and partners across various digital touchpoints, from web portals and mobile apps to chatbots and email campaigns. Because of Liferay’s DXP responsive design capabilities, insurance companies can not only establish and integrate these channels of communication, but they can also deliver a brand-consistent and optimized experience across all devices and channels, making it easier for customers and partners to interact with the company. Security and Compliance: Especially for Life Insurers and Health Insurers who have access to sensitive and personal customer information, security and compliance are paramount. Liferay provides robust security features and can be customized to meet industry-specific compliance requirements. It offers role-based access control, Single Sign On (SSO) capabilities, 2 factor authentication, encryption, and auditing capabilities to protect sensitive customer data while ensuring compliance with regulations like GDPR and HIPAA. Content Management and Knowledge Sharing: Liferay’s built-in content management system allows insurance companies to create and manage a wealth of information, from policy documents to educational resources. This capability along with its elastic search helps insurers educate customers, agents, and employees, improving self-service options, reducing support costs, and enhancing the overall customer experience. Analytics and Insights: Liferay provides analytics tools that allow insurers to gain insights into user behavior and engagement. Insurance companies can employ these analytics capabilities not only for their service and sales operations, but also for product planning, risk mitigation, marketing as well as business strategic planning purposes. Agents can get information like customer research history and insights that can help them identify the right product to offer. Decision makers can employ analytics to gain user behavior insights and customized dashboards that can provide them with real-time analytics while claims managers and underwriters can gain insights that can enable intelligent underwriting and connected claims management. Along with an integrated Ecosystem, Tailored Portals, and customized platforms, Liferay also helps insurance companies employ new digital capabilities: With the combination of Liferay OOTB offerings, customization from Liferay Development Partner, and its custom-tailored portals, insurance companies can gain the following digital platforms:  Intelligent Underwriting Platform: This portal can provide underwriters with advanced tools and data analytics to assess risks more effectively. It can integrate with data sources, predictive modeling, and machine learning algorithms to streamline the underwriting process and make it more data-driven. Connected Claims Management Platform: A claims management platform powered by Liferay can enable efficient claims processing. It can integrate with internal and external data sources, facilitate communication between claims adjusters, and provide customers with real-time updates on their claims status. Personalized Customer Relationships Platform: Liferay’s personalization capabilities can be leveraged to create a platform that tailors content and services to individual customers. It can use customer data to recommend policies, communicate through preferred channels, and offer a personalized experience throughout the customer journey. Product Ideation Portal: This platform can be used by insurance companies to collaborate on new product ideas and innovations. It can facilitate idea submission, evaluation, and development, bringing together teams from various departments to brainstorm and bring new products to market. Team Collaboration Portal: Liferay’s collaboration features can be utilized to create a platform for internal team collaboration. Insurance companies can use this portal for project management, document sharing, communication, and task tracking, enhancing teamwork and productivity. Conclusion: In the competitive landscape of the insurance industry, Liferay Insurance Portals and Liferay Enterprise DXP serve as a powerful tool for creating a digital ecosystem that caters to both the collective needs of the industry and the unique requirements of individuals.   Liferay’s DXP capabilities enable insurers to deliver personalized, secure, and efficient experiences that drive customer satisfaction, enhance agent productivity, and ensure compliance with industry regulations. With the help of an experienced Liferay Consulting Partner, insurance companies can get the right combination of portal, DXP core services,

Salesforce Personalization for MedTech- Delivering Data Security, Interoperability and Sustainability 

Salesforce Personalization for MedTech- Delivering Data Security, Interoperability and Sustainability Avakash Dekavadiya MedTech organizations are in turmoil to cope with the latest trends in the healthcare domain and to keep their medical wearable devices, cloud platforms, and digital health solutions relevant for users.   In the last 3 years, there has been a growing need to provide patients access to their information while ensuring data integrity and security of PHI, especially in the US.  Also, MedTech companies must create optimum data interoperability to justify their pricing and to battle the rising healthcare cost concerns with optimum data distribution channels.   Along with these, there are also rising challenges to fight climate change and meet the market demands for sustainability that have been surrounding Medical Device Manufacturers and DaaS as well as Cloud Intelligence companies utilizing multiple technology platforms and large data servers.   Whether we talk about Security, Data Interoperability, or Sustainable business approach, a platform that can provide all these capabilities and much more with its CRM and bundle of health cloud and MedTech services is Salesforce!   Along with an experienced Salesforce Consulting Partner that has experience and expertise in MedTech and the digital health domain, a MedTech company can personalize Salesforce for its integration, sustainability, regulatory, and data security requirements.   Create a futuristic business model and an integrated as well as sustainable digital ecosystem with Salesforce where data flows easily and securely and generates insights that not only deliver business intelligence but also help in optimum data distribution with HIPAA and FHIR compliances!  Understanding Salesforce’s capabilities for MedTech Data Security, Interoperability, and Sustainability: MedTech Data Security: When you employ Salesforce, MedTech companies can protect their data in a personalized as well as holistic manner. For instance, Salesforce provides a comprehensive and flexible data security model to secure data at three different levels- Objects, Fields, and records. When we talk about MedTech, objects would be the departments or inter-departmental functions for which Salesforce is used. For instance, for Salesforce Sales Cloud the inter-departmental functions would be Opportunities, Leads, Data, Campaigns, and others. Similarly, Salesforce provides 2 other layers of data security for Objects with access definitions for each field and record of a particular data set. Here fields refer to the columns or holistic category data and records refer to rows or individual data sets. To provide a brief, let’s say there is a data file that shares Patient Data or User Data of the Device and its usage history. Thus, when you are setting permissions and visibility of data, patients will have access to their personal information and not to all the other information. Non-medical professionals or specifically product QA teams can track details like usage and device failure data but not get access to the PHI of patients generated with the Medical Device. You can also set permissions and visibility for each user as well as user sets. MedTech Data Interoperability: To provide optimum data interoperability for healthcare providers and to MedTech companies thathave multiple data distribution channels or are a cloud-intelligence and DaaS platform, they can leverage Salesforce Data Interoperability solutions.  With multiple integration layers available across security, data, process, and applications, MedTech companies can create an integrated Digital Ecosystem with the help of a Salesforce Implementation Partner and create a unique combination of the Salesforce Build and Buy concept.   Along with internal interoperability, MedTech organizations can also leverage Salesforce’s API-driven interoperability for the external distribution of data! For instance, Salesforce provides FHIR, including MuleSoft FHIR RAML auto-generator for ready-to-use APIs. Along with a Salesforce Customization Partner, MedTech can personalize APIs as well as display templates to integrate device data with open EHRs and other external partner systems with Salesforce!   Sustainability in MedTech with Salesforce: To enable MedTech and MedDev companies to become carbon neutral and to provide accurate analysis on carbon emissions from energy usage and company travel, they can use Salesforce’s Net Zero-as-a-Service and become carbon neutral faster with complete data access and traceability.  With Salesforce Integrations, MedTech companies can collaborate with a Salesforce Partner and create a unified platform where all your data flows directly onto one platform. After defining all your carbon-emitting activities, Salesforce Consulting Partner can create a platform where decision-makers can quantify the carbon footprint across Scope 1, 2, and 3 emissions.   They can also formulate a climate action plan from a single source of truth and easily measure the progress to manage neutrality plans from one platform. With organization-aligned customization, MedTech companies can also manage all the changes in the plans, generate reports and share progress with the right stakeholders.  Looking for such Salesforce Applications and beyond? AIMDek is your right MedTech Salesforce Partner! Serving MedTech enterprises across the USA as a Salesforce Consulting Partner since 2014, with the collaborative power of Salesforce and our in-depth domain expertise, we serve Enterprises that are not just creating technology solutions but addressing integral humanity problems.​  To understand the timeline, cost, and the right Salesforce module customization of Salesforce 360 implementation that would deliver Data Security, Interoperability, and Sustainability, get on a consultation call with our Salesforce Expert Today!  skip render: ucaddon_next_prev_post